Tuesday, November 2, 2021

One of the Most Cutting Edge Companies Transforming Medicine

This could be one of the most cutting-edge companies transforming medicine that we've ever seen

Alzheimer's is horrendous, heartbreaking, and excruciating. It is characterized by the loss of cholinergic neurons in the brain. Decreased acetylcholine levels and loss of receptors negatively impact learning, memory, and function.

Suppose you've ever had a family member suffer from it.

In that case, you know exactly what I'm talking about and how soul-crushing it is to have a parent or grandparent, or aunt or uncle, not even know you.

The fact that there's still no satisfactory cure for this progressive neurodegenerative condition is despicable. Especially when you consider how many people it affects.

According to the Alzheimer's Association, this disease impacts an estimated 6 million people in the U.S. alone, with 1 person diagnosed every 65 seconds. Treatments are only getting more expensive too. The estimated healthcare cost for Alzheimer's and other dementias is roughly $355 Billion per year. It is expected to increase to more than $1.1 Trillion annually by 2050.

Luckily, this company's latest drug candidate is designed to optimize efficacious dose, minimize treatment-limiting side-effects and improve long-term outcomes.

Click here to learn more about this opportunity.


Disclaimer:
This email is a paid advertisement. It is for a product or service that is not offered, recommended or endorsed by Global Profit Systems, LLC and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered.

Disclaimer: Futures, forex, stock, and options trading are not appropriate for all traders. There is a substantial risk of loss associated with trading these markets. Losses can and will occur. No system or methodology has ever been developed that can ensure returns or against losses. No representation or implication is being made that using any of these methodologies or systems will generate returns or ensure against losses.

In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that Global Profit Systems, LLC and InvestingChannel, Inc. are being paid on a Cost-Per-Click basis which may exceed a fee of over $1000.00 in cash, from an unaffiliated third-party (“advertiser”) as compensation for the distribution of this advertisement. Global Profit Systems, LLC has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertisement, is to provide publicity for the advertiser, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of securities may result in the loss of your entire investment. You understand that this advertisement or our website constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. This advertisement is not a solicitation, offer, inducement, invitation or recommendation to buy securities, services or product of the advertiser. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of the advertiser, you should call your state securities regulator to determine if the security may be sold in your state. You should read and review, if and to the extent available, any information concerning the advertiser available at the websites of the U.S. Securities and Exchange Commission (the "SEC") at http://www.sec.gov and the Financial Industry Regulatory Authority (the "FINRA") at http://www.FINRA.org. Many companies have information filed with state securities regulators who may be able to supply you with additional information. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud available at http://www.sec.gov/consumer/cyberfr.htm, as well as related information published by FINRA on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence. We strongly encourage you to conduct your own research before making any investments decisions.

You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertiser, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of external websites, nor are we responsible for the content, advertising, opinions, products or other materials on external websites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email, external website or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates, and agents harmless. You acknowledge that you are not relying on us, and we are not liable for any actions taken by you based on any information contained in any disseminated email, website or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertiser.
 
This email was sent to edwardlorilla1986.paxforex@blogger.com by Global Profit Systems Intl LLC
6999-02 Merrill Road  | Jacksonville | FL | 32277
Forward to a friend | Unsubscribe

No comments:

Post a Comment

Trump's Secret Manhattan Project

                                                                                                          JANUARY 20: Trump To Launch New...